ABSTRAK
Malaria is one of the most contagious diseases that are still of a public health problem in the world including Indonesia. Malaria occurs in 106 countries. About 3.3 billion people live in endemic areas of malaria, and nearly 80% of malaria cases occur in the eastern part of Indonesia. 1 The prevalence of malaria reflected as annual malaria incidence ( While currently artemisinin has been shown to be effective for malaria treatment, some degree of resistance has been reported to occur worldwide. 3 Therefore, a malaria vaccine is likely to be used as a potential tool for malaria control. Merozoite surface protein 1 (MSP-1) is a potential candidate of malaria vaccine because the monoclonal antibodies raised against this protein show its capability to block erythrocyte invasion in vitro. 4 The MSP-1 is a major protein used by the Plasmodium during red blood cells invasion. 5 Merozoite is the smallest cell measuring 1-2 μm in the life cycle of Plasmodium. 6 The MSP-1 contains 2 epidermal growth factors (EGF-like domain) which are important parts during erythrocyte invasion. 7, 8 MSP-1 19 gene sequence located on block 17 is highly conserved. Therefore, it is used for the development of malaria vaccine. 9 Lactococcus lactis has a generally recognized as safe (GRAS) host cell status and is often used in expressing recombinant proteins. L. lactis has been characterized as a good microorganism for the industry and capable of secreting recombinant protein into its growth media, so that the resulting product is free of endotoxin. The construction and expression of the MSP-1 19 gene in L. lactis has been prepared before. 7 In the study, 10 The codon optimization is performed to remove the biased codons that can inhibit the production of recombinant proteins in the prokaryotic system. It is a strategy to improve the production efficiency of recombinant proteins in the prokaryotic system. The purpose of this study was to construct the expression vectors for the MSP-1 19 gene and to express MSP-1 19 recombinant protein L. lactis as a candidate for malaria vaccine.
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METHODS
Genes, plasmids, bacteria, growth media, and primers used in this study The material used in this study is the synthetic gene usp45-MSP-1 19 (GeneBank: AF165928) which is the result of codon optimization and has been ligated into the plasmid pMA-T. The growth media are Luria-Bertani (LB) and M17B bacteria. Plasmid used is pMA-T (cloning vector), and pNZ8148 is used as expression vector. Several vector and bacterial strains can be seen in Table 1 
Construction of expression vector
The construction of the expression vector began by isolating the pMA-T plasmid. The MSP-1 19 gene was obtained by digesting the fragment of interest using restriction enzymes on the Nco1 and Xba1 sites, followed by gel purification. Pure DNA fragments of MSP-1 19 were ligated into pNZ8148 expression plasmid using T4 DNA ligase enzyme prior to introduction into E. coli MC1061. The transformation to E. coli MC1061 was performed by the heat shock method. 11 Furthermore, pNZ8148-usp45-MSP-1 19 plasmid in E. coli MC1061 was isolated and subsequently transformed into L. lactis. Competent cells were grown in 0.2% L. lactis in 5 ml M17 broth + 0.5% glucose overnight at 30°C. Subsequently, the culture was incubated in 25 ml M17 broth containing 0.5% Glucose, 0.5 M sucrose, and 2.5% glycin overnight at 30°C. The culture was then put into 75 ml of M17 broth containing 0.5% glucose, 2.5% glycine, and 0.5 M sucrose and grown until the culture reached OD600 ~ 0.2-0.3 prior to harvesting the cell using centrifuge. Cells were resuspended with 0.5 M sucrose +10% glycerol. The transformation process was carried out using Gene Pulser BIORAD electroporation at 2,000 V, 25 μF, 260 Ω. The success of the transformation process of the pNZ8148-usp45-MSP-1 19 construct into L. lactis was confirmed by amplification of the bacteria colony by polymerase chain reaction (PCR), plasmid isolation followed by restriction enzyme digestion, and sequencing of inserts or plasmid construct.
pNZ8148-usp45-MSP-1 19 plasmid in L. lactis was grown further to increase the expression of the recombinant protein.
12 L. lactis carrying recombinant plasmid was grown in 5 ml of M17 medium that contained 0.5% glucose. A total of 1.5 ml of L. lactis culture was subjected by Strains and vector Relevant characteristics Source of reference
Bacterial strains
Escherichia coli MC1061 Bacterial/host strain for cloning MoBiTec
Lactococcus lactis NZ3900 Bacterial/host strain for expression MoBiTec Vector
pMA-T Cloning vector containing ampicillin resistance gene Invitrogen pNZ8148
The nisin-induced expression vector containing chloramphenicol resistance gene MoBiTec Table 1 . Bacterial strains and vector used in this study centrifugation at 10.000x g for 2 min. The pellet was resuspended with solution I containing 10 mM EDTA (pH 8.0), 25 mM Tris/HCl, 50 mM glucose, and 20 mg/ml lysozyme (Sigma) was added and subsequently incubated for 15 min at 37°C. The mixture was added with 300 μl fresh solution II containing 0.2 M NaOH, 2% SDS and incubated for 3 min at room temperature. As much as 170 μl solution III containing 1.2 M Tris/HCl (pH 7.0) and 2 M NaCl were added to the mixture. The mixture was subsequently homogenized with 500 μl phenol. The upper layer phase was mixed with 600 μl PCI (Phenol Chloroform Isoamyl alcohol) then it was centrifuged. Moreover, 600 μl of isopropanol was added and then subjected to incubation on ice for 15 min. The mixtures were subjected to centrifugation and washed with 70% ethanol. The pellet was dried and dissolved in 20 μl ddH2O and 5 μl of 1 mg/ml RNase. The results of plasmid isolation were then subjected to Nco1 and Xba1 restriction enzymes, PCR of the colonies, and DNA sequencing to confirm the inserts sites.
The schematic construction representation of the cloning vector pMAT and expression vector pNZ8148 which was expressed as a fusion protein pNZ8148-usp45-MSP-1 19 can be seen in Figure 1 .
Expression and purification of recombinant protein MSP-1 19
Expression of MSP-1 19 as heterologous protein inside L. lactis was conducted with nisin inducible controlled expression (NICE) system. Protein expression was performed by the following methods. The MSP-1 19 expression in L. lactis was started by inoculating 10% fresh culture into 100 ml M17 broth containing 10 μg/ ml chloramphenicol and 0.5% glucose without agitation at 30°C for 10 hours to reach OD600 ~ 0.5. Furthermore, induction was performed using 10 ng/ml nisin and incubated for 5 hours at 30°C. The cells were subjected to centrifugation at 10.000 rpm at 4°C for 30 min. The recombinant protein was subjected to precipitation with 45% ammonium sulfate 27.7 g and subsequently incubated at 4°C for 10 hours. The cells were subjected to centrifugation to form the pellet for further elution step with 50 mM Tris HCl pH 7.4. The pellet suspension was purified by stationary phase adsorption chromatography Sephadex-G50. A total of 1 mL of pellet suspension was incorporated into chromatographic column, and then eluted with 50 mM Tris HCl pH 7.4.
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Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis
The expressed proteins were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis SDS-PAGE analysis using 10% separation gel and 4% retaining gel to examine the molecular weight of MSP-1 19 . The recombinant protein was mixed with loading dye buffer (containing 50 mM Tris HCl pH 6.8, 2% SDS, 10% glycerol, 1% β-mercaptoetanol, 12.5 M EDTA, 0.02% bromophenol blue in distilled water) and was subjected to heating at 95°C for 10 min prior to SDS-PAGE gel electrophoresis at 100 V and 20 mA. The gel was stained with silver staining kit (Fermentas Silver Stain Kit).
Determination of total protein concentration
The total protein concentration was quantified with bicinchoninic acid (BCA) kit using standard bovine serum albumine (BSA) curve. The standard concentrations of BSA used were 25 μg/ml, 125 μg/ml, 250 μg/ml, 500 μg/ml, 750 μg/ml, 1,000 μg/ml, 1,500 μg/ml, and 2,000 μg/ml. Working reaction was made by mixing reagents A and B with a ratio of 50:1. The sample and working reaction were added in a microplate 96-well by sample:working reaction ratio of 1:20. Microplate was incubated at 37°C for 30 minutes, and then the reaction result was read at 540 nm wavelength using enzyme-linked immunosorbent assay (ELISA) reader (Thermo Scientific Multiskan EX Microplate Reader).
Dot blot hybridization
Ten μl of protein samples were spotted on top surface of the membrane prior to blocking with 10% skim milk in 1x tris-buffered saline (TBS) for 1 hour. The membrane was washed 3 times, for 15 min, 5 min, and 5 min with 0.1% TBS-Tween. Furthermore, the membrane was incubated with monoclonal MSP1 antibody for 1 hour, and washed again 3 times with 0.1% TBS-Tween. The IgG mouse alkaline phosphatase conjugates as a secondary antibody was used to incubate the membrane for 1 hour prior followed by the washing step. Staining was performed using nitro blue tetrazolium-5-bromo-4-chloro-3-indolylphosphate NBT-BCIP substrate solution. The membrane was immersed in BCIP/NBT solution (500 µl NBT solution, 500 µl BCIP solution, dan 4 ml distilled water) for 1-5 min at room temperature until the color was developed. When the dot blots were detected, the incubation process was stopped by soaking the membrane in distilled water.
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RESULTS
The gene used in this study was the synthetic gene usp45-MSP-1 19 that has been ligated into the pMAT plasmid. The first stage of making the expression construct was the isolation of pMATusp45-MSP-1 19 plasmid with Nco1 and Xba1 restriction enzymes to release the gene/insert from the plasmid. The usp45-MSP-1 19 gene was In this study showed the different concentration of total protein. The highest concentration of total protein was 0.936±0.04 mg/ml for cells that were induced with 10 ng/ml nisin. However, this was not significantly different with the concentration of total non-induced protein (0.549±0.03 mg/ml). The lowest concentration was the vector alone (0.188±0.04 mg/ml).
MSP-1 19 molecular weight was 10.45 kDa ( Figure  5A ) suggesting that the protein was expressed and secreted out of the cell due to addition of the usp45 signal peptide that was able to recognize the signal recognition particle (SRP). The expression of MSP-1 19 protein was shown by dot blot analysis tested by the MSP-1 19 monoclonal antibody as shown by the purple spot in the membrane ( Figure 5B ).
DISCUSSION
The expression vector construction in this study was initiated by the ligation of the usp45-MSP-1 19 synthetic gene into the pMAT plasmid. The inserts were verified using Nco1 and Xba1 restriction enzymes to separate plasmids and genes. . Sequencing analysis pNZ8148-usp45-MSP-119 protein recombinant. NisA -35, -10, 1: are the starting points of transcription, RBS is the ribosome binding region (Shine-Dalgarno) and terminator is the end point of transcription. The green color is the restriction site (Nco1/Xba1), the blue color is Usp45 signal peptide, the red color is merozoite surface protein 1 (MSP-119), and the three asterisk is the stop codon of a thick cell membrane structure. 17 This electroporation technique applied high electrical voltage passed in a short time. Thus, it formed a pore on the cell membrane that could be inserted with foreign DNA. Selection of transformants using chlorampenicol antibiotics was possible because the vector harbors, the chloramphenicolresistant genes, was used as selection marker. The addition of sucrose and glycine can help the transformation process to become more efficient.
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The ligation of usp45-MSP-1 19 gene into pNZ8148 vector which was successfully introduced into E. coli host MC1061 was drawn from research by Wu et al. 12 They introduced the vector into E. coli first and then to the L. Lactis, so that the efficiency of the transformation to L. lactis was high. The pNZ8148 expression vectors are known to not have a high vector replication level, but it is balanced by their two starting points of replication, repA and repC, which are easily recognized by E. coli and L. lactis, respectively. 19 Referring to Wu et al, 12 the gene inserted into the expression vector was first adapted to the addition of two nucleotide bases of CC after translational starting site fused with Nco1 restriction sites (CCATGG). This is because the Nco1 site has already contained the ATG as the starting point of translation leading to mistranslation start site at the Nco1 site. At the usp45-MSP-1 19 signal peptide gene sequence in the pNZ8148 vector (Figure 4) , there was NisA -35, -10, +1 as the transcription beginning of the ribosome-binding region/RBS (Shine-Dalgarno), TAA as the stop codon and it was terminated by a terminator as the ending point of transcription. 20 The usp45-MSP-1 19 gene was expressed in the nisin inducible expression (NICE) system. The expression of the MSP-1 19 recombinant protein was performed by the induction of 10 ng/mL nisin. Giving nisin as an inducer from the outside the cells will stimulate the start of transcription at the nisA promoter through nisK and nisR regulon integrated in chromosomal DNA of L. lactis. 21 Possible expression level is controlled by the concentration of nisin given from the outside. The results of this response will form a transcription factor that activates the promoter nisA, so that the transcription process by RNA polymerase can be functioning. 22 The presence of target protein bands in noninduced samples is expected due to basal activity causing the usp45-MSP-1 19 gene to be expressed even in the absence of nisin induction. This has been demonstrated in the Mohseni et al 21 study that NICE expression systems often exhibit basal expression activity (in the absence of induction) when expressed in Lactobacillus. In addition to adjusting the dose of nisin, several other ways can be used to increase the gene expression level, such as by substituting an inducible promoter to a constitutive promoter. In accordance to the results of Lages et al, 23 the administration of 10 ng/ml nisin induction in L. lactis increased gene expression, resulting in more protein than the non-induced. The concentrations of nisin has compared in the range between 0.5 and 5 ng/ml to induce the expression genes of antibacterial in L. lactis, and obtained the result that the highest of antibacterial was produced by L. lactis induced with nisin at 5 ng/ml by Mustopa et al. 24 Moreover, codon optimization can also be performed. Nisin concentration required for induction is very low, between 0.5-10 ng/ml, while the high concentration of nisin of more than 10 ng/ml used will have negative effect on the host because it can suppress the growth of L. lactis. 25 As stated in the results section, usp45 signal peptide was able to recognize signal recognition particle (SRP) indicated by the protein being successfully secreted outside the cell to the growing medium. The SRP will bring the prepeptide to the SRP receptor present in the membrane, which then will be brought to the protein translocation channel (PTC). The signal peptide opened the PTC, then the mature peptide was removed whereas the usp45 signal peptide would be cut by the peptidase.
Detection of MSP-1 19 protein was also seen from the dot blot hybridization test which is an immunological test whose function is similar to the western blot to detect the specificity of the reaction between the antigen and the antibody. In the samples induced with 10 ng/ml nisin, the positive results of the dot blot test were observed ( Figure 5B) . The results showed specific reactions between MSP-1 19 proteins with MSP1 monoclonal antibodies, seen from color developed on the membrane. Characterization of immunogenicity of primary antibodies tested by dot blot assays showed the result of 10.45 kDa MSP-1 19 antigen was reacted with anti-MSP1 specific antibodies.
In conclusion, this study showed that MSP-1 19 protein fused with usp45 as signal peptide has been successfully constructed and expressed inside the GRAS organism in L. lactis. This heterologous expression of MSP-1 19 protein by GRAS host cell can be expected as the candidate for mucosal malaria vaccine which could induce both mucosal and systemic responses. Although initial test of expressed MSP-1 19 with monoclonal antibody in vitro has showed a positive result, in vivo investigation related to the efficacy of induced antibody should be determined.
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